SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001682852-21-000010
Filing Date
2021-03-10
Accepted
2021-03-10 16:31:58
Documents
14
Period of Report
2021-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mrna-20210310.htm   iXBRL 8-K 37505
  Complete submission text file 0001682852-21-000010.txt   179802

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20210310.xsd EX-101.SCH 2426
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20210310_cal.xml EX-101.CAL 712
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20210310_def.xml EX-101.DEF 1645
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20210310_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20210310_pre.xml EX-101.PRE 12648
7 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20210310_htm.xml XML 11241
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 21730196
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences